https://techpapersworld.com/wp-content/uploads/2024/02/Explore-the-Future-of-5G-1280x720.jpg

Airspan Networks Holdings LLC (“Airspan”), a leading developer of 4G and 5G Open RAN solutions, proudly announces the signing of a strategic Memorandum of Understanding (MoU) with Pavo Group, a global provider of security and defense solutions. This partnership will leverage the combined expertise of both companies to revolutionize the deployment of mobile telecommunications for defense, security, and critical infrastructure networks. Pavo Group, with its extensive experience in defense and critical infrastructure technology, is uniquely...

https://techpapersworld.com/wp-content/uploads/2024/09/Exyte-acquires-TTP-Group-to-1280x720.jpg

Calluna Pharma AS (Calluna), a clinical stage biotechnology company pioneering first-in-class antibodies to treat inflammatory and fibrotic diseases, today announced the completion of Phase 1 clinical study for CAL101, Calluna’s lead product candidate. The study demonstrated a favorable safety, pharmacokinetic (PK) and immunogenicity profile for the mAb. CAL101 is a first-in-class mAb that targets S100A4, a damage-associated molecular pattern (DAMP) protein implicated in serious and life-threatening diseases, such as idiopathic pulmonary fibrosis and systemic sclerosis....

https://techpapersworld.com/wp-content/uploads/2024/03/Advocare-Taps-Fort-Health-1280x720.jpg

Dante Omics, a trailblazer in genomics-driven artificial intelligence solutions, is proud to announce that its cutting-edge laboratory in Italy has been awarded the internationally recognized ISO 9001:2015 certification for “Provision of genomic Next Generation Sequencing, analysis and interpretation services.” The ISO9001 certification was issued to Dante Labs Srl. This achievement marks a significant step in the company’s commitment to maintaining the highest standards in quality management, ensuring the delivery of innovative and reliable genomic solutions...

https://techpapersworld.com/wp-content/uploads/2024/07/Implantica-announces-excellent--1280x720.jpg

Bioptimus, a French startup building the reference AI foundation model in biology, is excited to announce that its best-in-class H-optimus-0 foundation model is now integrated into Proscia’s Concentriq® Embeddings, enabling data scientists and researchers in pathology and life sciences to achieve breakthroughs in AI development at unprecedented speed and scale. This integration adds H-optimus-0 to the collection of foundation models that Concentriq Embeddings makes available on the Concentriq software platform where an enterprise’s data is stored,...

https://techpapersworld.com/wp-content/uploads/2024/05/SciBase-receives-first-order-1280x720.jpg

SoundHound AI, Inc. (Nasdaq: SOUN), a global leader in voice artificial intelligence, today announced the results of an independent survey of car owners in the UK, France, and Germany, which found that the vast majority of regular drivers – nearly 4 in 5 – are likely to use a voice assistant with voice generative AI capabilities if available. “This survey data is consistent with what we’ve been seeing from real drivers using voice generative AI...

https://techpapersworld.com/wp-content/uploads/2024/10/NUCLIDIUM-Announces-First-Patient-Imaged-in-1280x720.jpg

NUCLIDIUM today announced that the first patient has been successfully imaged in a phase 1 clinical trial evaluating the company’s radiotracer candidate as a safe and accurate diagnostic and disease-staging imaging agent in prostate cancer patients. 61Cu-NuriProTM (61Cu-NODAGA-PSMA I&T) is the diagnostic component of NUCLIDIUM’s NuriProTM program, binding specifically to Prostate Specific Membrane Antigen (PSMA). PSMA has evolved as an established biomarker for the diagnosis, staging, and treatment of patients suffering from certain types of prostate cancer.1,2,3,4 61Cu-NuriPro is the...

https://techpapersworld.com/wp-content/uploads/2024/10/Elixirr-the-Global-Challenger-Consultancy-Acquires--1280x720.jpg

Elixirr, the established, global award-winning challenger consultancy, today announces the acquisition of Hypothesis, the US-based disruptive insights and strategy firm. “bringing the consumer to the decision-making table” With Hypothesis’ expertise in insights and strategy, Elixirr is now even better placed to deliver end-to-end solutions to existing and new clients – from the initial deep research and discovery through to defining the strategy and developing the technology required to deliver valuable impact. Hypothesis’ impressive roster of...

https://techpapersworld.com/wp-content/uploads/2024/10/Northern-Data-Group-Accelerates-Focus--1280x720.jpg

Northern Data AG (ETR: NB2) (“Northern Data Group”, “Northern Data” or “the Group”), a leading provider of AI and High-Performance Computing (HPC) solutions, today announces that it is exploring the divestment of its heritage crypto mining business, Peak Mining. The potential divestment of Peak Mining will solidify Northern Data as a pure-play AI Solutions business, which includes Europe’s largest Generative AI Cloud platform, and a portfolio of innovative, purpose-built Data Centers. Following Q3 2024 financial results,...

https://techpapersworld.com/wp-content/uploads/2024/10/Smiths-Detection-becomes-first-and-only-supplier-1280x720.jpg

Smiths Detection, a global leader in threat detection and security screening technologies, and a business of Smiths Group, is proud to announce that its iCMORE Automated Prohibited Items Detection Systems (APIDS) algorithm has received local approval from the Netherlands’ National Coordinator for Security and Counter-terrorism (NCTV). “national additional detection requirements for security equipment.” Smiths Detection becomes the first and only supplier to receive this prestigious approval, setting an industry benchmark and reinforcing its position as...

https://techpapersworld.com/wp-content/uploads/2024/10/Blue-Lake-Biotechnology-and-CyanVac-1280x720.jpg

Blue Lake Biotechnology, Inc., a clinical-stage intranasal vaccine company developing parainfluenza virus 5 (PIV5)-vectored vaccines that harness the full breadth of the immune system to protect against serious infectious diseases, and its affiliate CyanVac LLC, today announced the presentation of positive interim pediatric clinical data on BLB201, Blue Lake’s vaccine candidate against respiratory syncytial virus (RSV), at the 2024 ISV Annual Congress in Seoul, South Korea. The oral presentation also included discussion of Phase 1...